[1] |
Gong Yan, Chen Honglei.
Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer
[J]. Journal of International Oncology, 2024, 51(3): 186-190.
|
[2] |
Liu Bohan, Huang Junxing.
Research progress of solute carriers related genes in malignant tumors
[J]. Journal of International Oncology, 2023, 50(5): 280-284.
|
[3] |
Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.
lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway
[J]. Journal of International Oncology, 2023, 50(4): 202-207.
|
[4] |
Wang Yue, Hu Qun, Hou Yingwei.
Research progress in influences of epigenetic modifications on PD-L1 expression in tumors
[J]. Journal of International Oncology, 2022, 49(6): 345-348.
|
[5] |
Wang Liwei, Liang Hongsheng, Du Songlin, Chen Zhihao, Wang Qing, Gao Aili.
Research progress of avermectins in anti-tumor
[J]. Journal of International Oncology, 2022, 49(6): 353-356.
|
[6] |
Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing.
MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2
[J]. Journal of International Oncology, 2022, 49(4): 193-198.
|
[7] |
Pang Jingdan, Du Yingying, Da Jie.
Adverse reactions and treatment measures of advanced solid tumors treated with antibody-drug conjugates
[J]. Journal of International Oncology, 2022, 49(4): 220-224.
|
[8] |
Zeng Yan, Luo Pan, Wang Ziqi, Wu Weili.
Mechanism of drug induced ferroptosis in the treatment of head and neck tumors
[J]. Journal of International Oncology, 2022, 49(3): 173-176.
|
[9] |
Jin Jiahui, Chen Cunhai, Ma Xuezhen.
Effects of radiation-associated miRNA in radiotherapy for breast cancer
[J]. Journal of International Oncology, 2022, 49(12): 735-738.
|
[10] |
Jing Wenjun, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhao Lili, Zhang Xue, Wei Hongmei.
Molecular basis and clinical prospect of the miR-34 family for the treatment of gastric cancer
[J]. Journal of International Oncology, 2022, 49(11): 681-686.
|
[11] |
Yang Chi, Luo Changjiang.
Research progress on the background of inflammation, immunity and cholesterol metabolism in colorectal cancer
[J]. Journal of International Oncology, 2022, 49(10): 630-634.
|
[12] |
Luo Liyun, Lai Canhui, Liang Renpei, Yang Aiwu, Lin Zhimin.
Correlation between the expressions of miR-524-5p and SOX9 in advanced gastric cancer and their influences on chemotherapy efficacy and prognosis
[J]. Journal of International Oncology, 2022, 49(1): 45-50.
|
[13] |
Hong Anlan, Cao Meng, Wang Yan, Fang Fang.
Research progress on lncRNAs as members of ceRNA network in melanoma
[J]. Journal of International Oncology, 2022, 49(1): 61-64.
|
[14] |
Zhang Jing, Huang Shouguo, Xia Ying.
Mechanism study of CeRNA regulatory network mediating malignant tumor phenotype
[J]. Journal of International Oncology, 2021, 48(9): 544-548.
|
[15] |
Liu Pei, Pu Jiaze, Huang Wen, Wang Fei.
Expression differences of miR-200c, miR-19a and miR-155 in gefitinib sensitive and drug resistant NSCLC patients and their effects on prognosis
[J]. Journal of International Oncology, 2021, 48(7): 409-414.
|